Personal information

Emails & domains

Verified email domains

Keywords

PCNSL

Countries

Germany

Activities

Collapse all

Employment (1)

Medical Center - University of Freiburg: Freiburg, Baden-Württemberg, DE

2009-07-01 to present (Department of Medicine I)
Employment
Source: Self-asserted source
Elisabeth Schorb

Funding (4)

PRIMA-CNS: Konzeptentwicklungsphase zur Studie: Altersadaptierte Hochdosis-Chemotherapie gefolgt von autologer Stammzelltransplantation oder konventionelle Chemotherapie mit R-MP als First-Line Behandlung von älteren Patienten mit ZNS-Lymphom - eine randomisierte Phase III Studie

2020-04 to 2021-04 | Grant
Bundesministerium für Bildung und Forschung (Bonn, DE)
GRANT_NUMBER:

01KD1904
Source: Self-asserted source
Elisabeth Schorb

Age adapted high-dose chemotherapy and autologous stem cell transplant in elderly and fit primary CNS lymphoma patients - MARTA

2016-02 to 2021-06 | Grant
Else Kröner-Fresenius-Stiftung (Bad Homburg v.d.H., DE)
GRANT_NUMBER:

2016_A133
Source: Self-asserted source
Elisabeth Schorb

MARiTA - Age-adapted high-dose chemotherapy and autologous stem cell transplantation for eligible elderly PCNSL patients - a pilot trial

2015-01 to 2015-12 | Grant
Albert-Ludwigs-Universität Freiburg (Freiburg, DE)
Source: Self-asserted source
Elisabeth Schorb

Clinical Research Training in Hematology (CRTH)

Award
European Hematology Association (The Hague, NL)
Source: Self-asserted source
Elisabeth Schorb

Works (31)

Analysis of Driver Mutational Hot Spots in Blood-Derived Cell-Free DNA of Patients with Primary Central Nervous System Lymphoma Obtained before Intracerebral Biopsy.

The Journal of molecular diagnostics : JMD
2020-08 | Journal article
DOI: 10.1016/j.jmoldx.2020.07.002
PMID: 32745612
Contributors: Montesinos-Rongen M; Brunn A; Tuchscherer A; Borchmann P; Schorb E; Kasenda B; Altmüller J; Illerhaus G; Ruge MI; Maarouf M et al.
Source: Self-asserted source
Elisabeth Schorb via Europe PubMed Central

High-dose chemotherapy and autologous stem cell transplant in elderly patients with primary CNS lymphoma: a pilot study.

Blood advances
2020-07 | Journal article
DOI: 10.1182/bloodadvances.2020002064
PMID: 32722778
PMC: PMC7391148
Contributors: Schorb E; Kasenda B; Ihorst G; Scherer F; Wendler J; Isbell L; Fricker H; Finke J; Illerhaus G
Source: Self-asserted source
Elisabeth Schorb via Europe PubMed Central

Ibrutinib in patients with relapsed/refractory central nervous system lymphoma: A retrospective single-centre analysis.

British journal of haematology
2020-05 | Journal article
DOI: 10.1111/bjh.16759
PMID: 32452526
Contributors: Lauer EM; Waterhouse M; Braig M; Mutter J; Bleul S; Duque-Afonso J; Duyster J; Marks R; Reinacher PC; Prinz M et al.
Source: Self-asserted source
Elisabeth Schorb via Europe PubMed Central

Induction therapy with the MATRix regimen in patients with newly diagnosed primary diffuse large B-cell lymphoma of the central nervous system - an international study of feasibility and efficacy in routine clinical practice.

British journal of haematology
2020-01 | Journal article
DOI: 10.1111/bjh.16451
PMID: 31997308
Contributors: Schorb E; Fox CP; Kasenda B; Linton K; Martinez-Calle N; Calimeri T; Ninkovic S; Eyre TA; Cummin T; Smith J et al.
Source: Self-asserted source
Elisabeth Schorb via Europe PubMed Central

Rituximab in primary central nervous system lymphoma-A systematic review and meta-analysis.

Hematological oncology
2019-10 | Journal article
DOI: 10.1002/hon.2666
PMID: 31418878
Contributors: Schmitt AM; Herbrand AK; Fox CP; Bakunina K; Bromberg JEC; Cwynarski K; Doorduijn JK; Ferreri AJM; Illerhaus G; Issa S et al.
Source: Self-asserted source
Elisabeth Schorb via Europe PubMed Central

Age-adjusted high-dose chemotherapy and autologous stem cell transplant in elderly and fit primary CNS lymphoma patients.

BMC cancer
2019-03 | Journal article
DOI: 10.1186/s12885-019-5473-z
PMID: 30925912
PMC: PMC6440161
Contributors: Schorb E; Finke J; Ihorst G; Kasenda B; Fricker H; Illerhaus G
Source: Self-asserted source
Elisabeth Schorb via Europe PubMed Central

[Current Treatment Standards in PCNSL].

Deutsche medizinische Wochenschrift (1946)
2019-01 | Journal article
DOI: 10.1055/a-0601-0992
PMID: 30703833
Contributors: Schorb E; Illerhaus G; Finke J
Source: Self-asserted source
Elisabeth Schorb via Europe PubMed Central

Hyper-<i>N</i>-glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphoma.

Blood
2018-09 | Journal article
DOI: 10.1182/blood-2018-03-836932
PMID: 30249786
Contributors: Thurner L; Preuss KD; Bewarder M; Kemele M; Fadle N; Regitz E; Altmeyer S; Schormann C; Poeschel V; Ziepert M et al.
Source: Self-asserted source
Elisabeth Schorb via Europe PubMed Central

Novel agents for primary central nervous system lymphoma: evidence and perspectives.

Blood
2018-07 | Journal article
DOI: 10.1182/blood-2018-01-791558
PMID: 29986908
Contributors: Illerhaus G; Schorb E; Kasenda B
Source: Self-asserted source
Elisabeth Schorb via Europe PubMed Central

The MRZ reaction and a quantitative intrathecal IgG synthesis may be helpful to differentiate between primary central nervous system lymphoma and multiple sclerosis.

Journal of neurology
2018-03 | Journal article
DOI: 10.1007/s00415-018-8779-x
PMID: 29511863
Contributors: Hottenrott T; Schorb E; Fritsch K; Dersch R; Berger B; Huzly D; Rauer S; Tebartz van Elst L; Endres D; Stich O
Source: Self-asserted source
Elisabeth Schorb via Europe PubMed Central

Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial.

The Lancet. Haematology
2017-10 | Journal article
DOI: 10.1016/s2352-3026(17)30174-6
PMID: 29054815
Contributors: Ferreri AJM; Cwynarski K; Pulczynski E; Fox CP; Schorb E; La Rosée P; Binder M; Fabbri A; Torri V; Minacapelli E et al.
Source: Self-asserted source
Elisabeth Schorb via Europe PubMed Central

High-dose chemotherapy with autologous haematopoietic stem cell support for relapsed or refractory primary CNS lymphoma: a prospective multicentre trial by the German Cooperative PCNSL study group.

Leukemia
2017-05 | Journal article
DOI: 10.1038/leu.2017.170
PMID: 28559537
Contributors: Kasenda B; Ihorst G; Schroers R; Korfel A; Schmidt-Wolf I; Egerer G; von Baumgarten L; Röth A; Bloehdorn J; Möhle R et al.
Source: Self-asserted source
Elisabeth Schorb via Europe PubMed Central

High-dose thiotepa-based chemotherapy with autologous stem cell support in elderly patients with primary central nervous system lymphoma: a European retrospective study.

Bone marrow transplantation
2017-04 | Journal article
DOI: 10.1038/bmt.2017.23
PMID: 28436974
Contributors: Schorb E; Fox CP; Fritsch K; Isbell L; Neubauer A; Tzalavras A; Witherall R; Choquet S; Kuittinen O; De-Silva D et al.
Source: Self-asserted source
Elisabeth Schorb via Europe PubMed Central

High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study).

Leukemia
2016-11 | Journal article
DOI: 10.1038/leu.2016.334
PMID: 27843136
PMC: PMC5383936
Contributors: Fritsch K; Kasenda B; Schorb E; Hau P; Bloehdorn J; Möhle R; Löw S; Binder M; Atta J; Keller U et al.
Source: Self-asserted source
Elisabeth Schorb via Europe PubMed Central

High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trial.

The Lancet. Haematology
2016-07 | Journal article
DOI: 10.1016/s2352-3026(16)30050-3
PMID: 27476790
Contributors: Illerhaus G; Kasenda B; Ihorst G; Egerer G; Lamprecht M; Keller U; Wolf HH; Hirt C; Stilgenbauer S; Binder M et al.
Source: Self-asserted source
Elisabeth Schorb via Europe PubMed Central

Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial.

The Lancet. Haematology
2016-04 | Journal article
DOI: 10.1016/s2352-3026(16)00036-3
PMID: 27132696
Contributors: Ferreri AJ; Cwynarski K; Pulczynski E; Ponzoni M; Deckert M; Politi LS; Torri V; Fox CP; Rosée PL; Schorb E et al.
Source: Self-asserted source
Elisabeth Schorb via Europe PubMed Central

High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma--a randomized phase III trial (MATRix).

BMC cancer
2016-04 | Journal article
DOI: 10.1186/s12885-016-2311-4
PMID: 27098429
PMC: PMC4839072
Contributors: Schorb E; Finke J; Ferreri AJ; Ihorst G; Mikesch K; Kasenda B; Fritsch K; Fricker H; Burger E; Grishina O et al.
Source: Self-asserted source
Elisabeth Schorb via Europe PubMed Central

Afatinib in Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations Pretreated With Reversible EGFR Inhibitors.

The oncologist
2015-09 | Journal article
DOI: 10.1634/theoncologist.2015-0073
PMID: 26354527
PMC: PMC4591955
Contributors: Heigener DF; Schumann C; Sebastian M; Sadjadian P; Stehle I; Märten A; Lüers A; Griesinger F; Scheffler M; Afatinib Compassionate Use Consortium (ACUC)
Source: Self-asserted source
Elisabeth Schorb via Europe PubMed Central

Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma--a long-term follow-up study.

Annals of oncology : official journal of the European Society for Medical Oncology
2015-03 | Journal article
DOI: 10.1093/annonc/mdv002
PMID: 25725080
Contributors: Kasenda B; Schorb E; Fritsch K; Finke J; Illerhaus G
Source: Self-asserted source
Elisabeth Schorb via Europe PubMed Central

Efficacy of the irreversible ErbB family blocker afatinib in epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)-pretreated non-small-cell lung cancer patients with brain metastases or leptomeningeal disease.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
2015-01 | Journal article
DOI: 10.1097/jto.0000000000000380
PMID: 25247337
PMC: PMC4276567
Contributors: Hoffknecht P; Tufman A; Wehler T; Pelzer T; Wiewrodt R; Schütz M; Serke M; Stöhlmacher-Williams J; Märten A; Maria Huber R et al.
Source: Self-asserted source
Elisabeth Schorb via Europe PubMed Central

Experience with afatinib in patients with non-small cell lung cancer progressing after clinical benefit from gefitinib and erlotinib.

The oncologist
2014-09 | Journal article
DOI: 10.1634/theoncologist.2014-0103
PMID: 25232040
PMC: PMC4200993
Contributors: Schuler M; Fischer JR; Grohé C; Gütz S; Thomas M; Kimmich M; Schneider CP; Laack E; Märten A; Afatinib Compassionate Use Consortium
Source: Self-asserted source
Elisabeth Schorb via Europe PubMed Central

Chronic hepatitis E virus infection following allogeneic hematopoietic stem cell transplantation: an important differential diagnosis for graft versus host disease.

Annals of hematology
2014-07 | Journal article
DOI: 10.1007/s00277-014-2163-4
PMID: 25015055
Contributors: Bettinger D; Schorb E; Huzly D; Panning M; Schmitt-Graeff A; Kurz P; Bertz H; Finke J; Brass V; Thimme R et al.
Source: Self-asserted source
Elisabeth Schorb via Europe PubMed Central

Transfusion-transmitted hepatitis E in Germany, 2013.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
2014-05 | Journal article
DOI: 10.2807/1560-7917.es2014.19.21.20812
PMID: 24906377
Contributors: Huzly D; Umhau M; Bettinger D; Cathomen T; Emmerich F; Hasselblatt P; Hengel H; Herzog R; Kappert O; Maassen S et al.
Source: Self-asserted source
Elisabeth Schorb via Europe PubMed Central

Long-term cognitive function, neuroimaging, and quality of life in primary CNS lymphoma.

Neurology
2013-05 | Journal article
DOI: 10.1212/wnl.0b013e318297eeba
PMID: 23685932
PMC: PMC3770201
Contributors: Doolittle ND; Korfel A; Lubow MA; Schorb E; Schlegel U; Rogowski S; Fu R; Dósa E; Illerhaus G; Kraemer DF et al.
Source: Self-asserted source
Elisabeth Schorb via Europe PubMed Central

Prognosis of patients with primary central nervous system lymphoma after high-dose chemotherapy followed by autologous stem cell transplantation.

Haematologica
2013-01 | Journal article
DOI: 10.3324/haematol.2012.076075
PMID: 23300179
PMC: PMC3640122
Contributors: Schorb E; Kasenda B; Atta J; Kaun S; Morgner A; Hess G; Elter T; von Bubnoff N; Dreyling M; Ringhoffer M et al.
Source: Self-asserted source
Elisabeth Schorb via Europe PubMed Central

18F-FDG PET is an independent outcome predictor in primary central nervous system lymphoma.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
2012-12 | Journal article
DOI: 10.2967/jnumed.112.108654
PMID: 23249539
Contributors: Kasenda B; Haug V; Schorb E; Fritsch K; Finke J; Mix M; Hader C; Weber WA; Illerhaus G; Meyer PT
Source: Self-asserted source
Elisabeth Schorb via Europe PubMed Central

Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma--a long-term follow-up study.

Annals of oncology : official journal of the European Society for Medical Oncology
2012-04 | Journal article
DOI: 10.1093/annonc/mds059
PMID: 22473593
Contributors: Kasenda B; Schorb E; Fritsch K; Finke J; Illerhaus G
Source: Self-asserted source
Elisabeth Schorb via Europe PubMed Central

The prognostic value of serum methotrexate area under curve in elderly primary CNS lymphoma patients.

Annals of hematology
2012-03 | Journal article
DOI: 10.1007/s00277-012-1441-2
PMID: 22456893
Contributors: Kasenda B; Rehberg M; Thürmann P; Franzem M; Veelken H; Fritsch K; Schorb E; Finke J; Lebiedz D; Illerhaus G
Source: Self-asserted source
Elisabeth Schorb via Europe PubMed Central

Primary CNS lymphoma--radiation-free salvage therapy by second autologous stem cell transplantation.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
2010-11 | Journal article
DOI: 10.1016/j.bbmt.2010.11.011
PMID: 21093600
Contributors: Kasenda B; Schorb E; Fritsch K; Hader C; Finke J; Illerhaus G
Source: Self-asserted source
Elisabeth Schorb via Europe PubMed Central

Marked smoking-associated increase of cardiovascular risk in childhood type 1 diabetes.

International journal of adolescent medicine and health
2008-07 | Journal article
DOI: 10.1515/ijamh.2008.20.3.285
PMID: 19097567
Contributors: Schwab KO; Doerfer J; Hallermann K; Krebs A; Schorb E; Krebs K; Winkler K
Source: Self-asserted source
Elisabeth Schorb via Europe PubMed Central

Early atherosclerosis in childhood type 1 diabetes: role of raised systolic blood pressure in the absence of dyslipidaemia.

European journal of pediatrics
2007-03 | Journal article
DOI: 10.1007/s00431-007-0440-0
PMID: 17387514
Contributors: Schwab KO; Doerfer J; Krebs A; Krebs K; Schorb E; Hallermann K; Superti-Furga A; Zieger B; März W; Schmidt-Trucksäss A et al.
Source: Self-asserted source
Elisabeth Schorb via Europe PubMed Central
How many people are using ORCID?